Cancer Res Treat.  2024 Oct;56(4):1040-1049. 10.4143/crt.2024.003.

Development and Feasibility Evaluation of Smart Cancer Care 2.0 Based on Patient-Reported Outcomes for Post-Discharge Management of Patients with Cancer

• Kwon JA
• Yang S
• Koh SJ
• Noh YJ
• Kang DY
• Yang SB
• Kwon EJ
• Seo JW
• Kim Js
• Ock M

• KMID: 2560238
• DOI: http://doi.org/10.4143/crt.2024.003

Abstract

Purpose
A “Smart Cancer Care” platform that integrates patient-reported outcomes (PROs) with management has been established in Korea. This study focused on improving health behaviors and connecting patients to welfare services by introducing and assessing the feasibility of “Smart Cancer Care 2.0,” an enhanced version designed for monitoring complications post-cancer treatment.
Materials and Methods
Smart Cancer Care 2.0 was developed by conducting a literature review and consulting with expert panels to identify symptoms or variables requiring monitoring and management guidelines based on the treatment type. Qualitative and quantitative surveys were conducted to assess the feasibility of the app and web system based on the experiences of patients with cancer and healthcare workers.
Results
A total of 81 symptoms or variables (chemotherapy-, surgery-, radiotherapy-, rehabilitation-, and health management-related) were selected for management in Smart Cancer Care 2.0. PROs for these symptoms were basically categorized into three severity grades: preventive management, self-treatment, and consultation with a healthcare worker or visit to a healthcare institution. The overall mean scores in the feasibility evaluation by patients and healthcare workers were 3.83 and 3.90 points, respectively, indicating high usefulness.
Conclusion
Smart Cancer Care 2.0 leverages the existing information and communication technologies–based platform, Smart Cancer Care, and further includes health behaviors and welfare services. Smart Cancer Care 2.0 may play a crucial role in establishing a comprehensive post-discharge management system for patients with cancer as it provides suitable interventions based on patients’ responses and allows the regularly collected PROs to be easily viewed for streamlined care.

Keyword

Mobile applications; Patient reported outcome measures; Drug-related side effects and adverse reactions; Patient discharge

Reference

References

1. Debela DT, Muzazu SG, Heraro KD, Ndalama MT, Mesele BW, Haile DC, et al. New approaches and procedures for cancer treatment: current perspectives. SAGE Open Med. 2021; 9:20503121211034366.

2. Anand U, Dey A, Chandel AK, Sanyal R, Mishra A, Pandey DK, et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 2023; 10:1367–401.

3. Ando K, Hu Q, Kasagi Y, Oki E, Mori M. Recent developments in cancer research: expectations for a new remedy. Ann Gastroenterol Surg. 2021; 5:419–26.

4. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022; 72:409–36.

5. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022; 54:330–44.

6. Pyo J, Ock M, Lee M, Kim J, Cheon J, Cho J, et al. Unmet needs related to the quality of life of advanced cancer patients in Korea: a qualitative study. BMC Palliat Care. 2021; 20:58.

7. Koh SJ, Kang KA, Kim H, Cheon J, Im HS, Lee JH, et al. Perceptions of the meaning of life among Korean patients with advanced cancer: a mixed-methods study. Palliat Support Care. 2023; 21:658–69.

8. Lizan L, Perez-Carbonell L, Comellas M. Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel). 2021; 13:4615.

9. Lewandowska A, Rudzki G, Lewandowski T, Rudzki S. The problems and needs of patients diagnosed with cancer and their caregivers. Int J Environ Res Public Health. 2020; 18:87.

10. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016; 34:557–65.

11. Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021; 374:n1647.

12. Ruland CM, Andersen T, Jeneson A, Moore S, Grimsbo GH, Borosund E, et al. Effects of an internet support system to assist cancer patients in reducing symptom distress: a randomized controlled trial. Cancer Nurs. 2013; 36:6–17.

13. Kearney N, McCann L, Norrie J, Taylor L, Gray P, McGee-Lennon M, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer. 2009; 17:437–44.

14. Borosund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM. Comparing effects in regular practice of e-communication and Web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res. 2014; 16:e295.

15. Berry DL, Hong F, Halpenny B, Partridge AH, Fann JR, Wolpin S, et al. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014; 32:199–205.

16. Moradian S, Voelker N, Brown C, Liu G, Howell D. Effectiveness of Internet-based interventions in managing chemotherapy-related symptoms in patients with cancer: a systematic literature review. Support Care Cancer. 2018; 26:361–74.

17. Glasgow TE, McGuire KP, Fuemmeler BF. Eat, sleep, play: health behaviors and their association with psychological health among cancer survivors in a nationally representative sample. BMC Cancer. 2022; 22:648.

18. Kadravello A, Tan SB, Ho GF, Kaur R, Yip CH. Exploring unmet needs from an online metastatic breast cancer support group: a qualitative study. Medicina (Kaunas). 2021; 57:693.

19. Sin C, Kim H, Im HS, Ock M, Koh SJ. Development and pilot study of “Smart Cancer Care”: a platform for managing side effects of chemotherapy. BMC Health Serv Res. 2023; 23:922.

20. Richards HS, Blazeby JM, Portal A, Harding R, Reed T, Lander T, et al. A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery. BMC Cancer. 2020; 20:543.

21. Regional Cancer Center Support Program [Internet]. Goyang: National Cancer Center;2023. [cited 2023 Nov 26]. Available from: https://www.ncc.re.kr/main.ncc?uri=english/sub04_ControlPrograms05.

22. Avery KN, Richards HS, Portal A, Reed T, Harding R, Carter R, et al. Developing a real-time electronic symptom monitoring system for patients after discharge following cancer-related surgery. BMC Cancer. 2019; 19:463.

23. Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014; 32:1480–501.

24. Yang D, Wei X, Hong Q, Zhao C, Mu J. Patient-reported outcome-based prediction for postdischarge complications after lung surgery. Thorac Cardiovasc Surg. 2023; 71:671–9.

25. Kim D, Yoo SH, Seo S, Lee HJ, Kim MS, Shin SJ, et al. Analysis of cancer patient decision-making and health service utilization after enforcement of the Life-Sustaining Treatment Decision-Making Act in Korea. Cancer Res Treat. 2022; 54:20–9.

26. Lee HR, Lim C, Yun HG, Kang SH, Kim DY. Making an informed decision of Korean cancer patients: the discrepancy between a patient’s recall of information and the information needed for acquisition of radiotherapy informed consent. Support Care Cancer. 2018; 26:297–303.

27. Garavand A, Aslani N, Nadri H, Abedini S, Dehghan S. Acceptance of telemedicine technology among physicians: a systematic review. Inform Med Unlocked. 2022; 30:100943.

28. Champarnaud M, Villars H, Girard P, Brechemier D, Balardy L, Nourhashemi F. Effectiveness of therapeutic patient education interventions for older adults with cancer: a systematic review. J Nutr Health Aging. 2020; 24:772–82.

29. Youn BY, Jang BH, Cheon C, Ko SG. Implementing accountable care organizations with integrative medicine in Korean health care system. Integr Med Res. 2021; 10:100711.

30. Kim YE, Pyo J, Lee H, Jeong H, Park YK, Seo JW, et al. Relevance index regional variation by each disease and its essential medical field: a retrospective data analysis from 2016-2020 in Korea. J Korean Med Sci. 2023; 38:e130.